Catheter design primer for neurointerventionalists.
Catheter
Device
Technology
Journal
Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
25
08
2022
accepted:
21
11
2022
pubmed:
5
1
2023
medline:
5
1
2023
entrez:
4
1
2023
Statut:
ppublish
Résumé
Neurovascular catheter technology has rapidly evolved over the past decade. While performance characteristics are well known to the practitioner, the design features of these new-generation catheters and their implications on performance metrics remain a mystery to most clinicians due to the limited number of available resources. This knowledge gap hampers informed device choices and also limits collaboration between clinicians and engineers. To aid fellow neurointerventionalists, in this primer we have summarized the basic concepts of catheter design and construction.
Identifiants
pubmed: 36597952
pii: jnis-2022-019567
doi: 10.1136/jnis-2022-019567
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1117-1121Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: DFK received research support from Cerenovus, Insera Therapeutics, Medtronic, Microvention, Balt, Monarch Biosciences, Brainomix, MiVi, Stryker, and royalties from Medtronic, has ownership interests in Nested Knowledge, Superior Medical Experts, Marblehead Medical, Conway Medical, Monarch Biosciences, Piraeus Medical, serves in advisory boards of NoNo Inc. and Vesalio. MR received research support from Medtronic and Balt and served as a consultant to Anaconda Biomed, Medtronic, Cerenovus, Stryker, Philips, Apta Targets, received Honoria from Boehringer Ingelheim, Ischemia View, Balt, and serves on an advisory board of Sensome. OC received research support from, and has ownership interest in Laboratorios ERN S.A. JL received honoria from Medtronic.